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ABSTRACT                                                                                      
Role of Protein Kinase C Isotypes in 1,25-dihydroxyvitamin D3 Mediated Signal 
Transduction Through the 1,25D3 Membrane Associated, Rapid Response Steroid 
Binding Receptors in Chick Intestinal Cells 
by 
Sakara Tunsophon, Doctor of Philosophy                                                               
Utah State University, 2010 
Major Professor: Dr. Ilka Nemere                                                                                        
Department: Nutrition, Dietetics, and Food Sciences 
 
It is now accepted that 1,25(OH)2D3 mediates its rapid actions on the control of 
phosphate and calcium homeostasis through its membrane receptor termed the 1,25D3-
MARRS (membrane associated rapid response steroid binding) protein. I determined the 
various PKC isotypes involved in the rapid regulation of phosphate uptake and calcium 
extrusion in chick intestinal cells. 1,25(OH)2D3-mediated phosphate uptake was 
stimulated within 1 min after addition of the hormone. Western blot analyses on isolated 
intestinal cells treated with steroid hormone resulted in dose-dependent increases in 
PKCα and PKCβ in postnuclear centrifugation fractions, but not in the low speed 
centrifugation fractions. The highest immunoreactivity of PKCα was found after 
treatment of the cells with 300 pM 1,25(OH)2D3 and declined at 650 pM hormone, 
relative to corresponding controls, while the highest immunoreactivity of PKCβ was 
found in cells treated with either 300 pM or 650 pM 1,25(OH)2D3. Therefore, PKCα and 
PKCβ redistribution are likely to relate to the dose-response curve for both phosphate 
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uptake and calcium efflux, respectively. Using transfection of primary cultures of 
intestinal cells with siRNA for these two isotypes,  I found decreased 32P uptake in cells 
transfected with siRNA to either PKCα or PKCβ in both controls (relative to 
untransfected controls), and hormone-treated cells. Further study of the effect of chemical 
blockers for PKCα or PKCβ on phosphate uptake was conducted in suspensions of 
isolated intestinal cells. The results from these experiments also confirmed the findings 
from the siRNA experiments and demonstrated decreased 32P uptake in cells treated with 
1,25(OH)2D3 plus blockers in comparison with cells treated with  1,25(OH)2D3 alone.  
The effects of PKCα and PKCβ in steroid-mediated calcium extrusion were 
further investigated using siRNA for PKCα or PKCβ. We found the siRNA to PKCβ 
alone caused decreased calcium extrusion. We also found that the inhibitors of PKCβ, but 
not PKCα, caused significantly enhanced calcium uptake by decreasing calcium efflux 
from the cells. This result suggested that PKCβ might be involved in the rapid response 
of 1,25(OH)2D3-stimulated calcium extrusion. I used confocal microscopy to study the 
redistribution of PKCα and PKCβ in cells exposed to steroid hormone for 30 sec.  PKCα 
was found to increase significantly in the apical membrane after a 30 sec exposure of 
cells to 300- or 650 pM 1,25(OH)2D3. By comparison, anti-PKCβ immunofluorescence 
was found to increase significantly in the basal region of cells, relative to controls, 
following exposure of cells to 300 pM seco-steroid.  These combined results, lead me to 
conclude the involvement of both PKCα and PKCβ in the signal transduction mechanism 
of 1,25(OH)2D3-mediated phosphate uptake while PKCβ is involved in the mechanism of  
1,25(OH)2D3-mediated calcium efflux in chick intestinal epithelial cells. 
(95 pages) 
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CHAPTER 1                                                                                      
INTRODUCTION 
 
Vitamin D  
Vitamin D is biologically inactive, and it must be metabolized to its biologically 
active forms. Vitamin D is normally produced in the skin or taken up by the diet. During 
exposure to sunlight, 7-dehydrocholesterol (7-DHC) in the skin absorbs UV light to 
produce previtamin D3 and later vitamin D3. The vitamin D3 enters the blood circulation 
by binding with vitamin D binding protein, and is transported to the liver where it is 
metabolized to 25-hydroxyvitamin D3 [25(OH)D3] by an enzyme in the liver called 
vitamin D-25-hydroxylase (25-OHase). The 25-hydroxyvitamin D3 then goes to the 
kidney and is hydroxylated to form two active metabolites 1) 24,25-dihydroxyvitamin D3 
[24,25(OH)2D3] by 25-hydroxyvitamin D3-24-hydroxylase (24-OHase), and 2) 1,25-
dihydroxyvitamin D3 [1,25(OH)2D3]-the most potent stimulatory form of vitamin D-by 
25-hydroxyvitamin D3-1a-hydroxylase (1-OHase). Most of the physiological effects of 
vitamin D in the body are related to the activity of this metabolite (Holick 2003, 2004; 
Sutton and McDonald, 2003; DeLuca, 2004). However, there is also evidence showing 
that 24,25(OH)2D3 has physiological functions such as its effects on bone metabolism 
(Dean et al., 2001; van Leeuwen et al., 2001) and its role to suppress the rapid action of 
1,25(OH)2D3 in kidney (Khanal et al., 2007) and intestine (Nemere et al., 2006; Larsson 
et al., 2006).                                                                                                                             
 1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the steroid hormone which is well 
known for its functions to regulate phosphate and calcium homeostasis in many organs, 
especially in  intestine, kidney and bone. In addition to the control of mineral balance,  
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Fig. 1.1 Structure of vitamin D and its metabolites 
1,25(OH)2D3 is involved in many physiological responses such as cell proliferation and 
differentiation, immune modulation, control of blood pressure and insulin secretion  
(Christakos et al., 2003; Dusso et al., 2005; Norman, 2008). 
Mechanism of action                              
 The effect of 1,25(OH)2D3 are mediated through two mechanisms.  
 1. Genomic actions - The cellular actions of this hormone are due to the binding 
of the hormone to a nuclear vitamin D receptor (nVDR), and represents a slow 
mechanism since it is involved with gene transcription and protein synthesis, for example 
in bone matrix (Christakos et al., 2003). This ligand-receptor complex interacts with the 
retinoid X receptor, and regulates the expression of approximately 500 genes (Norman, 
2008).           
 2. Pregenomic or rapid response actions - There are some cellular responses that 
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are rapidly stimulated by 1,25(OH)2D3 and cannot be explained by the slow mechanism 
via nVDR. This action is mediated through the 1,25D3-MARRS receptor. The signal 
transduction pathway involved in the rapid stimulation of mineral transport can be 
activated through protein kinase C (PKC), phospholipase C (PLC), protein kinase A 
(PKA) and mitogen activated protein (MAP) kinase (de Boland and Norman, 1998; 
Farach-Carson and Nemere, 2003; Fleet, 2004; Norman et al., 2004).             
Phosphate homeostasis 
The regulation of phosphate homeostasis in the body is maintained primarily by 
intestinal absorption, renal excretion, and subsequently by bone remodeling under the 
control of parathyroid hormone (PTH), 1,25(OH)2D3, 24,25(OH)2D3 (Nemere, 1996a,b; 
Carpenter et al., 1996; Khanal et al., 2007) and phosphatonins (Berndt and Kumar, 2007). 
Phosphate is required by every cell for normal physiological functions and metabolic 
reactions such as energy metabolism, nucleic acid synthesis, bone mineralization, 
membrane function and cell signaling (Berndt et al., 2005).     
 Phosphate is abundant in the diet, and normally absorbed efficiently by the 
intestine. However, a prolonged period of taking excess amounts of phosphate is believed 
to result in bone impairment and aging (Takeda et al., 2004). Therefore control of the 
balance between phosphate input and output is important. Plasma phosphate homeostasis 
is maintained by absorptive and secretory fluxes in kidney, bone and intestine and 
sometimes muscle. Under physiological circumstances, the intestine plays a major role in 
regulation of phosphate. However, under normal events, the kidney plays a role in 
maintaining phosphate homeostasis. Along the different segments of small intestine, 
phosphate is normally taken up by passive paracellular transport along a concentration 
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gradient. Active transcellular transport occurs along the intestine as well but against an 
electrochemical gradient.  Transcellular transport of phosphate across the enterocytes 
involves at least three steps         
 1) transport across the brush border membrane via a mechanism consisting of 
Na+/Pi cotransporters, or the more recently discovered Npt2b transporter (Sabbagh et al, 
2009), and by PKC mediated signal transduction (Zhao and Nemere, 2005)  
 2) transport through the cytoplasm most likely occurs in vesicles (Nemere, 
1996b), and           
 3) transport across the basolateral membrane by a Na+ independent carrier 
mediated mechanism (Radanovic et al., 2005; Berndt and Kumar, 2007), and vesicular 
exocytosis.           
 In normal phosphate status, the amount of intestinal phosphate absorption is equal 
to the amount of renal phosphate excretion. Low serum phosphate induces the stimulation 
of 1α-hydroxylase in the kidney, subsequently increasing 1,25(OH)2D3 synthesis. The 
increased 1,25(OH)2D3, along with PTH results in increased intestinal absorption of 
phosphate in the small intestine of young, growing animals (Nemere et al., 2004). 
Additionally, 1,25(OH)2D3 increases renal reabsorption of phosphate in kidney and 
stimulates bone mobilization to release phosphate into the serum. Thus, these 
mechanisms are important to maintain normal phosphate in blood circulation. The 
opposite mechanisms will take place when phosphate in the circulation is high (Nemere 
and Larsson, 2002; Berdnt and Kumar, 2007; Nemere, 2007; Peery and Nemere, 2007). 
Calcium homeostasis        
 One of the most abundant elements in the body is calcium. Approximately 99% of 
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calcium is found in bones and teeth. The remainder is found in body fluids such as blood 
and cells of other tissues. Calcium is a crucial element that plays an essential role in 
several physiological and biochemical processes. It is needed for skeletal and smooth 
muscle contraction, blood coagulation, neuromuscular excitability, nerve impulse 
transmission, cell permeability, cell adhesion, hormone and enzyme secretion, 
stabilization and activation of proteins and enzymes. Calcium concentrations in the blood 
and extracellular fluid need to be maintained in order to preserve the normal 
physiological functions (Wasserman, 2005; Collins and Ghishan, 2006; Forsell et al., 
2006; Khanal and Nemere, 2008).        
 One of the major organs to regulate calcium homeostasis is the small intestine. 
Transcellular calcium transport across the intestine is a three step process (Bouillon et al., 
2003).           
 1) entry at the brush border membrane  by a Ca2+ channel  called TRPV6, or a 
calcium carrier such as H+/Ca2+ exchanger (Wasserman, 2005; Collins and Ghishan; 
2006).  TRPV6 delivery to the membrane is mediated by PKA (Khanal et al., 2008) 
 2) transcellular movement by a vesicular transport mechanism in which the Ca2+  
and calbindin enriched vesicles are transported vectorially along microtubules (Nemere et 
al., 1991; Sterling and Nemere, 2005; Khanal and Nemere, 2008; Khanal et al., 2008) 
mediated by PKA signal transduction. Another mechanism may be by tunneling through 
intracellular stores.         
 3) Extrusion at the basolateral membrane by Na+-Ca2+ exchanger and Ca2+ 
ATPase or by PKC-mediated vesicular exocytosis (Nemere and Campbell, 2000; Khanal 
and Nemere, 2008).          
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 In addition to the indicated actions on kidney and bone, PTH acts directly on 
intestine to increase calcium absorption (Khanal and Nemere, 2008). Calcium-sensing 
proteins in the parathyroid glands monitor serum calcium levels. In the event of a slight 
decrease in serum calcium, the parathyroid glands secrete PTH). PTH stimulates an 
enzyme in the kidney which is called 1α-hydroxylase, resulting in an increased 
production of 1,25(OH)2D3 (calcitriol), an active metabolite form of vitamin D. 
1,25(OH)2D3 and PTH activate the calcium transporter in the brush border membrane 
(BBM) of small intestine (Khanal et al., 2008), increasing absorption of calcium. Both 
1,25(OH)2D3 and PTH act on bone by increasing bone resorption (release) to increase the 
calcium concentration into the circulation. In the kidneys, 1,25(OH)2D3 and PTH increase 
calcium reabsorption. If the circulating calcium is high, the regulation will be in the 
opposite direction (Nemere, 2005; Perez et al., 2008; Khanal and Nemere, 2008). 
Protein Kinase C         
 PKC is a family of phospholipid-dependent serine-threonine kinases consisting of 
at least 10 known isoforms. It is a key enzyme involved in signal transduction in many 
cellular pathways such as cell proliferation and differentiation, membrane trafficking, 
cytoskeleton organization and modulation of ion transport. The isozymes are divided into 
three subgroups, based on their substrate specificity, Ca2+ and cofactor requirements: 
conventional (or classical), novel, and atypical isoforms (Farhadi et al., 2006). 
Conventional PKCs (cPKCs) consist of the PKCα, PKCβ, and PKCγ isoforms. The 
activation of this group requires Ca2+, diacylglycerol (DAG) (or phorbol ester), and 
phospholipids such as phosphatidylserine or phosphatidylcholine (Orsenigo et al., 2002). 
The novel (nPKCs) isoforms (PKCδ, PKCε, PKCη, and PKCθ) require DAG, but not 
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Fig. 1.2 Regulation of PTH and 1,25(OH)2D3 in calcium homeostasis  
Ca2+ for activation. The atypical (aPKCs) including PKCζ and PKCι/λ isoforms do not 
require Ca2+ or DAG for activation. Thus, cPKCs are Ca2+ dependent whereas nPKCs and 
aPKCs can be activated in a Ca2+ independent pathway (Parker and Murray-Rust, 2004).  
 PKC isoforms are distributed in various tissue and cell specific patterns and also 
exhibit differences in subcellular localization within cell types (Newton, 2001; Song et 
al., 2001). PKC activation is determined by measuring the intracellular translocation of 
an isoform to a membrane or cytoskeleton. We can measure protein redistribution after 
subcellular fractionation by western blotting or by immunostaining of intact cells 
(Dempsey et al., 2000). 
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Fig. 1.3 Domain Structure of Protein Kinase C  
Statement of Problems 
The effects of 1,25(OH)2D3 are mediated in part through slower transcriptional 
mechanisms over a period of hours and are initiated by the nuclear vitamin D receptor 
(VDR), and possibly the 1,25D3-MARRS receptor (Nemere et al., 2000; Rohe et al., 
2007), as well as by rapid responses occurring within seconds to minutes,  mediated 
through membrane-initiated signal transduction pathways (Farach-Carson and Nemere, 
2003).           
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 Balogh et al. (2000) have shown an altered subcellular distribution of specific 
PKC isozymes after short incubations with 1,25(OH)2D3 in rat duodenum, and that 
hormone regulated enzyme modulation and redistribution were impaired with aging.  
Phosphate uptake        
 Previous studies (Zhao and Nemere, 2002; Nemere et al., 2004) have 
demonstrated that intestinal cells from chicks can be rapidly stimulated to take up 
phosphate through a signal transduction pathway mediated by protein kinase C (PKC). 
This mechanism can be activated via the 1,25D3-MARRS receptor, which is identical to 
PDIA3 (Nemere et al., 2004). The studies also showed decreasing phosphate uptake with 
increasing age which was correlated with decreasing PKC activity.   
 In rat, membrane initiated signaling relies on both cell surface VDR and the 
1,25D3-MARRS receptor, whereas in chick intestinal cells, only the 1,25D3-MARRS 
receptor is required (Nemere, 2005). Studies with ribozymes in chick intestinal cells have 
demonstrated that the 1,25D3-MARRS receptor is responsible for steroid hormone-
stimulated phosphate uptake and activation of PKC (Nemere et al., 2004).  
Calcium extrusion          
 In the facilitated diffusion model of calcium transport, calcium extrusion at the 
basolateral membrane (BLM) is mediated by an ATP-dependent Ca2+ pump and Na+-Ca2+ 
exchanger (Wasserman et al., 1992; Khanal et al., 2008). The purpose of this mechanism 
is to prevent the accumulation of divalent cation which is toxic to the cells.  While we 
have identified the PKA signaling pathway as the likely mediator of calcium uptake in 
intestinal cells (Phadnis and Nemere, 2003; Sterling and Nemere, 2007), PKC signaling 
has been identified in calcium extrusion (Nemere and Campbell, 2000) possibly by 
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facilitating exocytosis of vesicular transport calcium. Similarly, the study of Farhadi et al. 
(2006) indicated that PKC normalized intracellular calcium by modulating calcium 
efflux.            
 Ca2+ dependent protein kinases are known to regulate the activity of several 
membrane bound ion channels and carriers in various tissues, thereby modulating 
transmembrane ion transport (Halet et al., 2004). In small intestine, various kinds of PKC 
isoforms have been identified at the mRNA or protein level, including cPKCs (Farhadi et 
al., 2006).           
 Up to now, data concerning the effect of PKC activation on phosphate (Zhao and 
Nemere, 2002; Nemere et al., 2004) and calcium transport (Balogh et al., 1997; Larrson 
and Nemere, 2003) in the small intestine have been incomplete. The purpose of this study 
was to examine which Ca2+ dependent PKCs modulate the transport systems involved in 
steroid-mediated phosphate uptake and calcium extrusion, in order to provide a more 
detailed understanding of how intracellular signaling mechanisms regulate the transport 
of ions. 
Specific Aims 
The specific aims of the proposed research are to:     
 1.) Identify the cPKCs involved in 1,25(OH)2D3 stimulated rapid phosphate 
uptake           
 2. ) Identify the cPKCs involved in 1,25(OH)2D3 stimulated calcium extrusion 
Part I – Protein Kinase C isotypes in signal transduction for the 1,25D3-MARRS 
receptor (ERp57/PDIA3) in steroid hormone-stimulated phosphate uptake  
11 
 
Hypothesis                      
“cPKCs are involved in the mechanism of signal transduction of 1,25D3-stimulated 
phosphate uptake”                                                                                    
Objectives          
 1.) To determine the conventional protein kinase C (cPKC) redistribution in 
response to 1,25(OH)2D3 in isolated intestinal cells      
 2.) To identify the role of cPKCs in 1,25(OH)2D3 mediated phosphate uptake in 
cultured intestinal epithelial cells using siRNA to PKC specific isotypes  
 3.) To evaluate cPKCs in 1,25(OH)2D3 mediated phosphate uptake in isolated 
intestinal cells using PKC chemical blockers to specific isotypes 
Part II – Protein Kinase C isotypes in signal transduction for the 1,25D3-MARRS 
receptor (ERp57/PDIA3) in steroid hormone-stimulated calcium extrusion  
Hypothesis                       
“cPKCs are involved in the mechanism of signal transduction of 1,25D3-stimulated 
calcium extrusion”                 
Objectives          
 1.) To determine the role of PKCα and β in 1,25(OH)2D3 mediated calcium 
extrusion in cultured intestinal epithelial cells using siRNA to specific PKC isoforms 
 2.) To evaluate the role of PKCα and β in 1,25(OH)2D3 mediated calcium 
extrusion in isolated intestinal cells using PKC chemical blockers to specific isoforms
 3.) To evaluate PKCα and β redistribution pattern in response to 1,25(OH)2D3 by 
using confocal microscopy. 
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CHAPTER 2 
PROTEIN KINASE C ISOTYPES IN SIGNAL TRANSDUCTION FOR THE 1,25D3-
MARRS RECEPTOR (ERp57/PDIA3) IN STEROID HORMONE-STIMULATED 
PHOSPHATE UPTAKE1 
 
Abstract 
I undertook studies to determine which isotype(s) of protein kinase C (PKC) is/are 
activated by ligand binding to the 1,25D3-MARRS receptor (ERp57/PDIA3) and 
subsequent stimulation of phosphate uptake.  Isolated intestinal epithelial cells were 
exposed to 1,25(OH)2D3 for 1, 3, or 5 min, thoroughly chilled, homogenized, and P2 
fractions (20,000 x g post-nuclear pellet) prepared.  Western analyses with anti-pan PKC 
revealed steroid-stimulated redistribution to P2 membranes 1 min after hormone.  Using 
this time point, cells were treated with vehicle control, 130 pM-, 300 pM- or 650 pM- 
hormone.  Western blots with anti-PKCα exhibited redistribution to membranes in a 
biphasic dose-response curve: slightly stimulated at the lowest dose, maximal at 300 pM 
1,25(OH)2D3, and equivalent to control levels at the highest dose, paralleling hormone-
mediated phosphate uptake.  Westerns with anti-PKCβ also revealed hormone-mediated 
differences, while those with anti-PKCγ did not.  RNAi studies were then performed with 
siRNA against PKCα or PKCβ.  Untransfected cells treated with hormone for 7 min 
exhibited enhanced 32P uptake relative to vehicle controls. Cells transfected with either 
active siRNA revealed decreased 32P uptake in both controls (relative to untransfected 
controls), and hormone treated cells. However, control and treated transfected cells had 
equivalent levels of uptake. Western blot analyses confirmed decreased immunoreactivity  
1Coauthored by Sakara Tunsophon and Ilka Nemere                           
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in transfected cells. PKCα and PKCβ blockers also confirmed the results from siRNA 
and demonstrated decreased 32P uptake in cells treated with 1,25(OH)2D3 plus blockers in 
comparison with cells treated with  1,25(OH)2D3 alone.            
Introduction 
The regulation of phosphate in the body is maintained by intestinal absorption, 
renal excretion, and bone remodeling under the control of parathyroid hormone (PTH), 
1,25- dihydroxyvitamin D3 [1,25(OH)2D3], and 24,25-dihydroxyvitamin D3 
[24,25(OH)2D3] [1,2]. Phosphate is required for normal cellular functions and 
physiological processes such as energy metabolism, nucleic acid synthesis, bone 
mineralization, and cell signaling [3]. The effects of 1,25(OH)2D3 are mediated through 
slower transcriptional effects over a period of hours initiated by the nuclear vitamin D 
receptor (VDR), and possibly the 1,25D3-MARRS receptor [4,5]  and by rapid responses 
occurring within seconds to minutes,  mediated through membrane-initiated signal 
transduction pathways [6].            
 We have demonstrated in previous studies that 1,25(OH)2D3 mediated phosphate 
uptake in isolated chick intestinal cells exactly parallels the observations in perfused 
duodenal loops [7], indicating uptake is across the brush border. We have also found that 
1,25(OH)2D3 mediated phosphate uptake decreases with increasing age and is correlated 
with decreasing protein kinase C (PKC) activity [7,8]. PKCs are a family of 
phospholipid-dependent serine-threonine kinases. It is a key enzyme in regulation of cell 
growth and differentiation and modulation of ion transport. Balogh et al. [9] have shown 
the altered subcellular distribution of specific PKC isozymes after short incubations with 
1,25(OH)2D3 in rat duodenum, and that hormone regulated enzyme modulation and 
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redistribution were impaired with aging.       
 In rat, membrane initiated signaling relies on both cell surface VDR and the 
1,25D3-MARRS receptor, whereas in chick intestinal cells, only the 1,25D3-MARRS 
receptor is required [10]. Studies with ribozymes in chick intestinal cells have 
demonstrated that the 1,25D3-MARRS receptor is responsible for steroid hormone-
stimulated phosphate uptake and activation of PKC [8]. In the present study we test the 
involvement of several isozymes in steroid-mediated phosphate uptake. While others [11-
13] have catalogued isoforms activated by 1,25(OH)2D3 activity, we are the first to relate 
specific isotypes to the physiological endpoint of phosphate uptake. 
Material and Methods 
Animal and Surgical Methods 
All protocols were approved by the Institutional Animal Care and Use Committee 
at Utah State University (Logan, UT). White leghorn cockerels (Privett Hatchery; 
Portales, NM) were obtained on the day of hatch and raised for 3-7 wks on a vitamin D-
replete diet (Nutrena Feeds; Murray, UT). On the day of the experiments, chicks were 
anesthetized with chloropent (0.3 ml/100 g body weight), the duodenal loop was removed 
to ice-cold 0.9% saline and chilled for 15 min. The pancreas was excised and the 
duodenal loop was everted and rinsed three times with ice-cold saline. 
Cell Isolation  
The intestinal epithelial cells were isolated as previously described [8,14]. The 
everted duodenal loop was gently stirred for 15 min at 23oC  in citrate chelation solution 
containing 96 mM NaCl, 27 mM NaCitrate.2H2O, 1.5 mM KCl, 8 mM KH2PO4, 5.6 mM 
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Na2HPO4, pH 5.0. The intestinal segment was then transferred to fresh solution and cells 
released in the previous incubation transferred to 50-ml conical centrifuge tubes. The 
isolation protocol was repeated two more times. The cells were collected by low speed 
centrifugation (500 x g, 5 min, 4oC). Cell pellets were resuspended in Gey’s Balanced 
Salt Solution (GBSS, 119 mM NaCl, 4.96 mM KCl, 0.22 mM KH2PO4, 0.84 mM 
NaHPO4, 1.03 mM MgCl2.6H2O, 0.28 mM MgSO4.7H2O, 0.9 mM CaCl2, pH 7.4). To 
minimize clumping, the cells were gently spread along the walls of the centrifuge tube 
with a Teflon rod at room-temperature, and GBSS added drop-wise, with stirring, until a 
suspension was formed.  
Time Course and Dose-Response Studies 
Six ml of cell suspension was pipetted into each of six conical centrifuge tubes 
and incubated with vehicle (0.012% ethanol, final concentration) or 300 pM 1,25(OH)2D3 
for 1, 3, or 5 min (time course study, 23oC). Cells were then thoroughly chilled on ice for 
10 min prior to collection by centrifugation (500 x g, 5 min,  4oC). The pellets were 
homogenized with 20 strokes in 8 ml of homogenization medium containing 250 mM 
sucrose, 5 mM histidine-imidazole, 2 mM EGTA, pH 7.0 [15] and centrifuged at 1000 x 
g, 20 min, 4oC. The pellets (P1) were resuspended in 4 ml of homogenization medium and 
stored frozen until further use. The post-nuclear supernatant fractions were centrifuged at 
20000 x g, 10 min, 4oC to yield pellet fractions  (P2), which were resuspended in 200 µl 
of homogenization medium and also frozen until used for Western analyses as described 
below. P1 pellets contain nuclei, brush borders and large cell debris. P2 pellets contain 
basal lateral membranes, Golgi, mitochondria, lysosomes and peroxisomes [16].           
For dose response studies, similar procedures were used except incubation of the cells 
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occurred with vehicle or 130, 300 and 650 pM of 1,25(OH)2D3 hormone for 1 min. 
Cell Culture 
For studies with siRNA against PKCα or PKCβ (Ambion, Austin, TX), cells were 
resuspended in 40 ml of GBSS and aliquots (0.2 ml) pipetted into 35 mm plastic Petri 
dishes (Falcon, Fisher Scientific; Franklin Lakes, NJ) with 3 ml of RPMI-1640 medium 
(Hyclone, Logan, UT), and antibiotics containing 100 units/ml of penicillin and 100 
µg/ml of streptomycin (Sigma Chemical Co; St. Louis, MO). The cells were incubated 
overnight at 37oC, 5% CO2/95% air without serum to promote cell adherence. The 
following day, medium was aspirated and the cells were transfected with SiImporter 
(Millipore, Bedford, MA) as described by the manufacturer’s product protocol (Upstate, 
Lake Placid, NY, 2005) with 100 nM siRNA,  final concentration (Ambion, Austin, TX). 
Briefly, for each plate 930 µl of RPMI-1640 medium was combined with 65 µl of a 
solution containing 5 µl of SiImporter, 25 µl of siRNA diluent, 35 µl of RPMI-1640 and  
5 µl of siRNA (transfected cells) or scrambled RNA (Santa Cruz Biotechnology, Santa 
Cruz, CA) or without siRNA (mock transfected cells), mixed gently and incubated at 
room temperature for 5 min. The transfection mixture was then added to the cultured 
cells and incubated for 4 hrs. After the incubation period, 3 ml of RPMI-1640 with 10% 
FBS and antibiotics were added to each Petri dishes (Falcon Scientific Products; Franklin 
Lakes, NJ). Incubation was continued for 24 hrs at 37oC, 5% CO2/95% air and the 
cultures were assayed for phosphate uptake as described below.   
Phosphate Uptake                                                                                                          
 After 48 hours of incubation, the medium was aspirated and replaced with 1 ml of 
GBSS containing 0.1% BSA (23oC). At T = 0, an equal volume of buffer was added 
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containing radioactivity (2 µCi of H332PO4 [Perkin Elmer Life Sciences, Boston, MA] per 
ml, final concentration) and either vehicle (0.012% ethanol, final concentration) or 300 
pM 1,25(OH)2D3 (final concentration), and the incubation continued for 7 min—a time 
found earlier to be optimal for observing hormone-mediated differences in uptake [17]. 
Media were then aspirated and the cells were rinsed with 4 ml of ice-cold GBSS three 
times, followed by the addition of 0.5 ml of lysis buffer (0.1% (v/v) triton X-100 in TED 
containing 10 mM Tris, 1.25 mM EDTA, 2mM dithiothreitol, pH 7.4). Cells were 
scraped, solubilized and collected for determination of radioactivity by liquid scintillation 
spectrophotometry and protein. The remaining samples were frozen for Western analyses.  
SDS-PAGE and Western Analyses 
Protein samples were separated on 8% (w/v) SDS-polyacrylamide gel with a 5% 
stacking gel. After separation on SDS-PAGE, proteins were transferred to polyvinylidene 
difluoride (PVDF) membranes (Immobilon-P, Fisher Scientific, Dallas, TX) by using a 
Trans-Blot SD semidry transfer cell (Bio-Rad Laboratories, Inc., Hercules, CA) at 15 V 
for 1 h. The membrane was soaked in blocking solution containing 0.5% nonfat dry milk 
in phosphate buffered saline (PBS) for 1 h at 37oC to prevent non specific binding. The 
membrane was then washed three times, 5 min each, with wash buffer containing 0.1% 
(w/v) BSA in Tris-buffered saline (TBS; 0.02% NaN3 and 0.9% NaCl in 20 mM Tris-
HCl, pH 7.4), followed by incubation overnight at 4oC with primary antibody: either the 
anti-pan PKC (1/500, Zymed, San Francisco, CA), anti-PKCα (1/20000, Sigma-Aldrich), 
anti-PKCβ (1/500, Zymed) or anti-PKCγ (1/1000, Zymed) in antibody incubation 
solution (1 % BSA and 0.05% TWEEN-20 in TBS). In addition, we incubated 
membranes as well with Ab593 (1/500) which is an antibody against 1,25D3-MARRS 
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receptor (generated by the multi-antigenic peptide technique) and used as a loading 
control. The following day, the membrane was washed three times and incubated with 
alkaline phosphatase-conjugated secondary antibody for 1 h at room temperature 
(1/5000-10000 as specified by instructions in the ECF kit (Amersham Biosciences, 
Piscataway, NJ), followed by three additional washes. After that, the PVDF membrane 
was incubated with ECF substrate for 30 min. Bands were visualized with the ECF 
substrate using a Kodak Image Station 2000R. Band intensity from Westerns were 
quantified by pixel intensity using Adobe Photoshop CS2. 
Cell Suspension 
Chicken intestinal cells were isolated by citrate chelation as described above and 
were resuspended in room temperature Gey’s Balanced Salt Solution (GBSS; 23oC) 
containing 0.1% BSA. Fourteen milliliters of cell suspension was pipetted into a 
polypropylene tube which contained 2 μCi/ml of H332PO4 or 1 μCi/ml of 45CaCl2, final 
concentration (Perkin Elmer Life Sciences, Boston, MA), at T = -10 min. Aliquots (3.2 
ml) of cell suspension were pipetted into four fresh tubes and samples (100 μl) were 
removed at T = -5 and -1 min to establish basal uptake. At T = 0 min, the cells were 
treated with the vehicle ethanol (final concentration < 0.05%) or 300 pM 1,25(OH)2D3 to 
produce the following incubation conditions: (1) controls (2) 300 pM 1,25(OH)2D3 (3) 
control plus PKCα blocker (4) 300 pM 1,25(OH)2D3 plus PKCα blocker. Another series 
of experiments were done with the same procedures to produce the following conditions: 
(1) controls (2) 300 pM 1,25(OH)2D3 (3) control plus PKCβ blocker (4) 300 pM 
1,25(OH)2D3 plus PKCβ blocker.                
At T = 1, 3, 5, 7, and 10 min, 100 μl samples were pipetted into 900 μl of ice-cold GBSS 
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to stop uptake. Cell samples were placed on ice and centrifuged (1,000 x g, 5 min, 4oC) at 
the end of the time course. The supernatants were decanted and the tubes were swabbed 
with a Kimwipe while still in the inverted position. The pellets were resuspended in 500 
μl of double-distilled water. The aliquots (100 μl) were pipetted into 3 ml of liquid 
scintillation cocktail for the determination of radioactivity and 20 µl of aliquots were 
taken to determine protein by the Bradford reagent. Specific radioactivity (cpm/μg 
protein) was calculated and then values obtained for the treated phase were normalized to 
average basal phase.  
Protein Determination 
The protein concentration was determined using Bradford reagent (BioRad) and 
bovine γ-globulin as the protein standard. 
Statistical Analysis 
All values were expressed as mean + SEM. Statistical comparisons between two 
treatment groups were compared by one way ANOVA (SigmaStat 3.1 and SigmaPlot 
9.0). Significant differences were considered to occur at P < 0.05. 
Results 
Time course of 1,25(OH)2D3-mediated redistribution              
of protein kinase C in isolated intestinal epithelial cells 
 
Time course studies were undertaken by incubating cell suspensions with vehicle 
(0.012% ethanol, final concentration) or 300 pM 1,25(OH)2D3 for 1, 3, or 5 min, 
followed by thorough chilling prior to centrifugation.  Cell pellets were homogenized, 
and P1 and P2 fractions prepared. Western analyses of P1 fractions with an anti-pan PKC 
primary antibody failed to detect any hormone-mediated redistribution of PKC 
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immunoreactivity (data not shown) under the present conditions. By comparison, P2 
fractions did exhibit hormone- and time-dependent redistribution of immunoreactivity.  A 
representative immunoblot (n = 3) is presented in Fig. 1A. The highest level of 
immunoreactivity occurred in cells treated with 1,25(OH)2D3 for 1 min (Fig 2.1A). 
Figure 2.1B presents the results of 3 independent experiments expressed as a ratio of  
immunoreactive fluorescence in samples prepared from 1,25(OH)2D3 treated cells 
relative  to corresponding control values. The ratios for 1, 3, and 5 min of incubation 
were 1.397 + 0.087,  1.245 + 0.042 and 1.092 + 0.026, respectively.  Thus, 1,25(OH)2D3 
treatment for 1 min resulted in an 40% increase in PKC associated with P2 membranes (P 
< 0.01, relative to controls). The 1 min time point was subsequently chosen for dose 
response studies using PKC-isotype specific antibodies. 
Dose-response studies with isotype-specific antibodies 
The dose response studies were performed with procedures equivalent to those 
used in the time course studies.  Cells were incubated with vehicle or 130 pM, 300 pM or 
650 pM 1,25(OH)2D3 for 1 min (n = 3), thoroughly chilled, and then homogenized for 
preparation of P2 fractions.  A representative Western using anti PKCα and Ab593 as 
primary antibodies are shown in Fig 2.2A. Cells treated with 300 pM 1,25(OH)2D3 were 
found to have the highest immunoreactivity in subsequently prepared P2 fractions.  
Quantitation of the results for 3 experiments are presented in Fig 2.2B in which a ratio of 
fluorescence intensity in samples from steroid treated cells are related to control values. 
Both are normalized to the band intensities of the 1,25D3-MARRS-binding  protein. The 
ratios were 1.218 + 0.078, 1.540 + 0.048 (**P < 0.1) and 1.140 + 0.052, relative to other 
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Fig. 2.1 (A) Western analysis with anti-pan-PKC. Enterocytes were isolated with citrate 
chelation and collected by centrifugation at 500 x g for 5 min, 4oC. Cell pellets were 
resuspended in GBSS, and 6 ml of suspension incubated with vehicle or 300 pM of 
1,25(OH)2D3 for 1, 3, or 5 min. Cells were then thoroughly chilled on ice prior to 
collection by centrifugation. Cell pellets were homogenized in homogenization medium 
and P2 fractions prepared. Aliquots of P2 pellets (25-50 µg) were separated on 8% (w/v) 
SDS-polyacrylamide gel with 5% stacking gel and transferred to PVDF. Cells were 
incubated by using the anti-pan PKC and Ab593 as primary antibodies followed by 
alkaline phosphatase conjugated secondary antibody. Bands were visualized with the 
ECF substrate using a Kodak Imager. Upper bands are Pan PKC and lower bands are the 
1,25D3-MARRS receptor. Lanes 1, 3 and 5 were controls at 1, 3, and 5 min, respectively 
(1C, 3C and 5C), lanes 2, 4, and 6 were cells incubated with 1,25(OH)2D3 for 1, 3, and 5 
min, respectively (1D, 3D and 5D).  
Fig. 2.1 (B) After subtracting background, the mean intensity of the anti-pan-PKC bands 
were calculated as a ratio of 1,25(OH)2D3 treatment at 1, 3, and 5 min, relative to 
corresponding control values. Data are represented as mean + S.E.M. for three 
independent experiments (*P value < 0.05 and **P value < 0.01, relative to the ratio at 5 
min). 
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concentrations for 130 pM-, 300 pM-, and 650 pM 1,25(OH)2D3, respectively. These 
results—a biphasic dose-response curve with optimum at 300 pM steroid hormone—
closely parallel 1,25(OH)2D3-stimulated phosphate uptake [9].    
 Western analyses with anti PKCβ (Fig. 2.3A) and anti PKCγ (Fig 2.4A) were also 
performed. Increased anti PKCβ immunoreactivity in P2 fractions of hormone-treated 
intestinal epithelial cells was observed after 130-, 300-, and 650 pM steroid (Fig. 2.3A). 
Quantitations of the results for 3 experiments is presented in Fig 2.3B in which a ratio of 
fluorescence intensity in samples from steroid treated cells are related to control values. 
The ratios were 1.041 + 0.045, 1.461 + 0.134 (**P value < 0.01) and 1.520 + 0.091 (**P 
value < 0.01), for 130 pM-, 300 pM-, and 650 pM 1,25(OH)2D3, respectively. While 
these data most closely parallel 1,25(OH)2D3-stimulated calcium uptake, they also 
indicate PKCβ may be involved in steroid-stimulated phosphate uptake.  
 Equivalent experiments with anti-PKCγ as primary antibody indicated there was 
no effect of 1,25(OH)2D3 on redistribution of immunoreactivity (Fig. 2.4A). Quantitation 
of the results for 3 experiments is presented in Fig 4B in which a ratio of fluorescence 
intensity in samples from steroid treated cells are related to control values. There were no 
significant differences among treatment groups. The ratios were 1.075 + 0.0.078, 0.966 + 
0.072 and 1.055 + 0.059, for 130 pM-, 300 pM-, and 650 pM 1,25(OH)2D3, respectively.  
Effect of siRNA against PKCα or PKC β on                                                                 
phosphate uptake in cultured intestinal cells 
 
 The results of the dose response studies suggested that either PKCα and/or PKCβ 
is/are  the isotypes most likely mediating 1,25(OH)2D3-stimulated phosphate uptake in  
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Fig. 2.2 (A) Western analysis with anti-PKCα. Isolated cells were prepared as described 
in the legend to Fig 2.1 and incubated for 1 min with vehicle or a range of hormone 
concentrations. P2 fractions were prepared for Western analysis using anti-PKCα and 
Ab593 as primary antibodies. Upper bands are PKCα and lower bands are the 1,25D3‐
MARRS receptor. Lane 1 was control (CON), lanes 2, 3 and 4 were fractions from cells 
incubated with 130-, 300-, or 650 pM 1,25(OH)2D3, respectively (130, 300, or 650).  
(B) Band intensity of anti-PKCα. Data were calculated as described in the legend to Fig. 
2.1 for three independent experiments (**P value < 0.01, relative to intensity ratios 
calculated for cells incubated with 130-, or 650 pM 1,25(OH)2D3).  
 
31 
 
 
 
Fig. 2.3 (A) Western analysis with anti-PKCβ. Procedures were as described in the legend 
to Fig 2.2, and Westerns performed using anti-PKCβ and Ab593 as primary antibodies. 
Upper bands are PKCβ and lower bands are the 1,25D3‐MARRSreceptor. Lane 1, control 
(CON), lanes 2, 3 and 4 were fractions from cells incubated with 130-, 300-, or 650 pM 
1,25(OH)2D3, respectively (130, 300 and 650). 
(B) Band Intensity of anti-PKCβ. Data were calculated as described in the legend to Fig. 
2.1 for three independent experiments (**P value < 0.01, relative to cells incubated with 
130 pM 1,25(OH)2D3).  
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Figure 2.4 (A) Western analysis with anti-PKCγ. Procedures were as described in Fig 
2.2, and Westerns performed using anti-PKC γ and Ab593 as primary antibodies. Upper 
bands are PKCγ and lower bands are the 1,25D3‐MARRS receptor. Lane 1, control 
(CON), lanes 2, 3, and 4 were fractions from cells incubated with 130-, 300-, or 650 pM 
1,25(OH)2D3, respectively (130, 300 and 650). 
(B) Band intensity of anti-PKCγ. Data were calculated as described in the legend to Fig. 
2.1 for three independent experiments. 
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intestinal epithelial cells. Therefore, we further investigated whether knockdown of 
PKCα gene expression-would affect phosphate uptake. In this study, we cultured 
intestinal cells as previously described [10,16], and transfected some of the cultures with 
siRNA against PKCα. In initial studies, cells were cultured for 72 h as recommended by 
the manufacturer.  However, it was observed that this resulted in loss of 1,25(OH)2D3-
stimulated PKC activity. The duration of tissue culture was subsequently reduced to 24 h 
after transfection. Under these conditions a significant increase in phosphate uptake was 
observed in nontransfected cells incubated with 1,25(OH)2D3. By comparison, cells 
transfected with siRNA to PKCα showed a significant decrease in phosphate uptake in 
both vehicle controls and hormone treated cells, relative to nontransfected controls (Fig. 
2.5A).            
 Data presented in Fig. 2.5B indicate that a 300 pM 1,25(OH)2D3 treatment 
stimulated phosphate uptake in non transfected cells and cells transfected with scrambled 
siRNA to a similar extent.  No such stimulation was observed in cells transfected with 
siRNA against PKCβ. We used Western blot analysis to confirm decreased PKCα and 
PKCβ levels in transfected cells relative to nontransfected cells (Figs. 2.6A and 2.6B, 
respectively). The results showed a significant decrease in immunoreactivity of PKCα in 
transfected cells (TF PKCα) by 74% (P < 0.001) when compared with nontransfected  
cells (NTF). Transfection with siRNA against PKCβ produced a 42% knockdown in  
expression (P < 0.001).  
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Fig. 2.5 (A) Effect of siRNA against PKCα on phosphate uptake in cultured intestinal 
cells. Isolated cells were resuspended in 40 ml of GBSS (Gey’s balanced salt solution) 
and 200 µl pipetted into 35 mm plastic Petri dishes containing 3 ml of RPMI-1640 
medium and antibiotics (100 units/ml penicillin, 100 mg/ml streptomycin, Sigma). The 
cells were incubated for 24 h (in the absence of serum) at 37 °C with 5% CO2/95% air to 
promote cell adhesion and then transfected. The transfection protocol is described in 
materials and methods. After 24 h, cultured cells were incubated with or without 300 pM 
1,25(OH)2D3 in 1 ml of GBSS/0.1% (wt/vol) BSA containing 4 µCi of H332PO4 for 7 
min. The cells were rinsed 3 times with 4 ml ice-cold GBSS, followed by the addition of 
0.5 ml of 0.1% (vol/vol) Triton X-100 in 10 mM TED to each plate. Cells were scraped 
and radioactivity determined by liquid scintillation counting. Data are represented as 
mean + S.E.M. for nine to eighteen independent experiments (**P < 0.01, ***P < 0.001, 
relative to corresponding controls).  
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Fig. 2.5 (B) Effect of siRNA against PKCβ on phosphate uptake in cultured intestinal 
cells. Isolated cells were resuspended in 40 ml of GBSS (Gey’s balanced salt solution) 
and 200 µl pipetted into 35 mm plastic Petri dishes containing 3 ml of RPMI-1640 
medium and antibiotics (100 units/ml penicillin, 100 mg/ml streptomycin, Sigma). The 
cells were incubated for 24 h (in the absence of serum) at 37 °C with 5% CO2/95% air to 
promote cell adhesion and then transfected. The transfection protocol is described in 
materials and methods. After 24 h, cultured cells were incubated with or without 300 pM 
1,25(OH)2D3 in 1 ml of GBSS/0.1% (wt/vol) BSA containing 4 µCi of H332PO4 for 7 
min. The cells were rinsed 3 times with 4 ml ice-cold GBSS, followed by the addition of 
0.5 ml of 0.1% (vol/vol) Triton X-100 in 10 mM TED to each plate. Cells were scraped 
and radioactivity determined by liquid scintillation counting. Data are represented as 
mean + S.E.M. for nine to eighteen independent experiments (**P < 0.01, ***P < 0.001, 
relative to corresponding controls).  
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Fig. 2.6 Western analysis with anti-PKCα or PKCβ in nontransfected cells and cells 
transfected with siRNA. Intestinal cells were cultured as described in the legend to Fig. 
2.5. Westerns were run (A) using anti-PKCα and as a primary antibody or (B) anti PKCβ 
as primary antibody. Lanes 1 and 2 were nontransfected cells, lane 3 and 4 were 
transfected cells. 
 
Effect of PKCα blocker (safingol) PKC β blocker                                                               
([3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl-)                                                                      
4-anilino-1H-pyrrole-2,5-dione]) on phosphate uptake                                                       
in intestinal cell suspensions 
 
The results of PKCα/β blockers confirmed the results from the previous study 
that these two PKC isotypes are involved in mediating 1,25(OH)2D3-stimulated 
phosphate uptake in intestinal epithelial cells.  The result from PKCα blocker 
experiments demonstrated a significant decrease in phosphate uptake in cells treated with 
300 pM 1,25(OH)2D3 plus safingol at 3, 7 and 10 min (0.987 + 0.032dd, 0.812 + 0.071dd, 
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0.853 + 0.055dd, respectively, ddP value  < 0.01) when compared with cells treated with 
1,25(OH)2D3  at the same time point (1.374 + 0.109, 1.280 + 0.080, 1.227 + 0.081) (Fig 
2.7A). Whereas the results from PKCβ blocker experiments showed a statistically 
significant decrease in phosphate uptake in intestinal cells treated with  300 pM 
1,25(OH)2D3 plus PKCβ blocker at 1, 3, 5, 7 and 10 min (1.056 + 0.025dd, 0.930 + 
0.148dd, 0.980 + 0.073ddd, 0.988 + 0.067dd, 0.997 + 0.049dd, respectively, dd,dddP value < 
0.01, 0.001 ) when compared with cells treated with 1,25(OH)2D3  at the same time 
points (0.0947 + 0.042, 1.018 + 0.070, 0.903 + 0.140, 0.933 + 0.046, 0.933 + 0.141, 
respectively (Fig 2.7B). 
Discussion 
We have previously reported that phorbol ester—a stimulator of PKC activity—
increases phosphate uptake in chick intestinal cells [7,17],  whereas forskolin—an 
activator of adenylate cyclase—does not [7]. Protein kinase C isozymes consist of lipid 
dependent serine/threonine kinases which include Ca2+ -dependent, Ca2+ -independent or 
novel forms. Although PKC isotypes are similar in structure, they differ in subcellular 
and tissue distribution, suggesting that they have different functions [11]. In the current 
study we have found that the biphasic dose response curve for PKCα redistribution to 
subcellular membranes most closely parallels that for 1,25(OH)2D3-mediated phosphate 
uptake and transport [7]: increasing stimulation up to an optimal concentration of 300 pM 
steroid, followed by inhibition at 650 pM hormone.  By comparison, 1,25(OH)2D3-
stimulated PKCβ activity exhibited activation at both 300- and 650 pM hormone, which 
corresponds more closely with stimulated calcium transport [18].  While we have  
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Fig. 2.7 
A) Effect of the chemical PKCα blocker (safingol) on phosphate uptake in intestinal cell 
suspensions. Enterocytes isolated by citrate chelation were resuspended in Gey’s 
Balanced Salt Solution (GBSS; 23oC) containing 0.1% BSA and combined with 2 μCi/ml 
of H332PO4, final concentration, at the start of the time course studies. Aliquots of cells 
were pipetted into four fresh tubes and samples (100 μl) were removed at T = -5 and -1 
min to establish basal uptake. At T = 0 min, the cells were treated with the vehicle 
ethanol (final concentration < 0.05%) or 300 pM 1,25(OH)2D3 to produce the following 
incubation conditions: (A) (1) controls (open circles)      (2) 300 pM 1,25(OH)2D3  
(closed circles) (3) controls in the presence of the PKCα blocker (open triangles) (4) 300 
pM 1,25(OH)2D3 in the presence of the PKCα blocker (closed triangles) .  
(B) Effect of the chemical PKC β blocker ([3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl)-
4-anilino-1H-pyrrole-2,5-dione]) on phosphate uptake in intestinal cell suspensions. 
Another series of experiments were done with the same procedure to produce the 
following conditions:  (1) controls (open circle)  (2) 300 pM 1,25(OH)2D3 (closed circles)  
(3) controls in the presence of the PKCβ blocker  (open triangles) (4) 300 pM 
1,25(OH)2D3 in the presence of the PKCβ blocker (closed triangles). At T = 1, 3, 5, 7, 
and 10 min, 100 μl samples were pipetted into 900 μl of ice-cold GBSS. Cell samples 
were centrifuged (1,000 x g, 5 min, 4oC), supernatants decanted and pellets analyzed for 
radioactivity and protein. Specific radioactivity (cpm/μg protein) was calculated and then 
values obtained for the treated phase were normalized to average basal phase. (aa,cc,dd P < 
0.01, relative to controls, controls plus PKCα/β blockers and 1,25(OH)2D3 plus PKCα/β 
blockers, respectively). Data are presented as mean treated/average basal ratios + SEM. 
(aaa,ccc,ddd P < 0.001, relative to controls, controls plus PKCα/β blockers and 1,25(OH)2D3 
 
identified the PKA signaling pathway as the likely mediator of calcium uptake in 
intestinal cells [19,20], PKC signaling has been identified in calcium extrusion [21]. 
Similarly, the study of Farhadi et al. [22] indicated that PKC normalized intracellular 
calcium by modulating calcium efflux.       
 However, we tested the potential role of either isotype in hormone-stimulated 
phosphate uptake in experiments with siRNA. Further support for the role of PKCα in 
steroid-enhanced phosphate uptake comes from studies with siRNA.  Transfection of 
intestinal cells with this reagent resulted in both decreased protein levels of the enzyme 
and inhibition of 1,25(OH)2D3-mediated increases in 32P uptake.  Our finding that  
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siRNA transfection of cells that were then treated with vehicle also showed decreased 
phosphate uptake relative to non transfected vehicle controls, suggests that PKCα activity 
also contributes to basal efflux. Equivalent experiments with siRNA against PKCβ 
further support a role of this isotype in 1,25(OH)2D3–stimulated phosphate uptake as 
well.           
 Additional experiments were performed to examine the role of PKCα and PKCβ 
in 1,25(OH)2D3-mediated phosphate uptake in cell suspension studies. The results 
confirmed our previous siRNA studies and indicate that both PKCα and PKCβ are 
involved in the signal transduction mechanism of steroid-mediated phosphate uptake in 
intestinal cells.          
 In duodenum of young rats by comparison, Balogh et al. [9] found 1,25(OH)2D3-
induced redistribution of PKC α, β, and δ to various compartments including nucleus and 
cellular membranes.  Using rat colonocytes, Wali et al. [12] found steroid-enhanced 
activation of PKC α, and βII in brush border membranes relative to basal lateral 
membranes.  Thus, this signal transduction pathway is clearly central to the rapid actions 
of 1,25(OH)2D3 in intestine.  Differences in relative contributions of any given isotype 
are most likely due to species differences.  
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CHAPTER 3 
PROTEIN KINASE C ISOTYPES IN SIGNAL TRANSDUCTION FOR THE 1,25D3-
MARRS RECEPTOR (ERp57/PDIA3) IN STEROID HORMONE-STIMULATED 
CALCIUM EXTRUSION2       
 
Abstract 
Protein kinase C (PKC) is involved in the rapid 1,25(OH)2D3-mediated extrusion 
of calcium in chick intestinal epithelial cells. The previous report demonstrated that 
PKCα and PKCβ redistribution corresponded to the dose-response curve for calcium 
extrusion. We verified the role of both PKCα and PKCβ in hormone-stimulated calcium 
extrusion by using chemical inhibitors of PKCα (safingol) and PKCβ ([3-(1-(3-Imidazol-
1-ylpropyl)-1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione]) in intestinal cell 
suspensions. The results demonstrated that blocking PKCβ activity inhibited the 
extrusion of calcium (resulting in increased calcium uptake) from intestinal cells treated 
with 1,25(OH)2D3 when compared with vehicle controls (P < 0.001). While the PKCα 
blocker did not show any difference in calcium extrusion among the treatment groups. 
Similar results were also found in further experiments with transfection of siRNA to 
PKCα or PKCβ in primary  intestinal cell culture. The results also indicated that there 
was no change in calcium extrusion in cells transfected with siRNA to PKCα, whereas 
the siRNA to PKCβ significantly decreased calcium extrusion in 1,25(OH)2D3-treated 
cells when compared with the corresponding hormone-treated cells in transfected and 
nontransfected cells (P < 0.01). Using confocal microscopy, we reduced the hormone 
2Coauthored by Sakara Tunsophon and Ilka Nemere                             
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exposure to 30 sec in order to view redistribution of PKCα and PKCβ. Rapid 
redistribution of anti-PKCα immunoreactivity was found to significantly increase 
fluorescence in the apical membrane region after a 30 sec exposure of cells to 300- or 650 
pM 1,25(OH)2D3 (P < 0.01 and 0.001, respectively). By comparison, anti-PKCβ 
immunofluorescence was found to increase significantly in the basal lateral region of the 
cells, relative to controls after the exposure of cells to 300- (P < 0.01) or 650 pM (P < 
0.05) seco-steroid. The results suggest that PKCβ is the PKC isotype involved in 
1,25(OH)2D3-mediated calcium efflux in intestinal epithelial cells. 
Introduction 
Calcium, the most abundant mineral in the body is an essential ion. It plays an 
important role in a variety of physiological functions including structural (skeleton and 
teeth) and signaling functions (muscle contraction, nerve impulse conduction, hormone 
and enzyme secretion, and as a secondary messenger in several pathways). Therefore, the 
control of calcium concentrations in the blood and extracellular fluid is necessary to 
maintain the normal functions of cells as well as the prevention of calcium accumulation 
in the cells (Wasserman and Fullmer, 1995; Forsell et al., 2006). Normally, the input and 
output of calcium is adjusted to the physiological needs of the body. Either in normal or 
disturbed calcium homeostasis, cells will have the way to control events to protect them 
from cytotoxicity (Khanal and Nemere, 2008). 1,25(OH)2D3 is one of the active 
metabolites if vitamin D and has been reported to maintain calcium homeostasis (Khanal 
and Nemere, 2008; Bronner, 2009; Oudshoorn et al., 2009) and it has been suggested that  
PKC signal transduction is involved and mediated through the 1,25D3-MARRS receptor 
(Nemere, 2005).  
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A  previous report demonstrated that PKC signaling has been identified in 
calcium extrusion (Nemere and Campbell, 2000; Khanal et al, 2008) possibly by 
facilitating exocytosis of vesicular transport calcium (Sterling and Nemere, 2005), 
whereas the PKA signaling pathway is the likely mediator of calcium uptake in intestinal 
cells (Phadnis and Nemere, 2003; Sterling and Nemere, 2007; Khanal et al., 2008). 
Studies in rat duodenum (Balogh et al., 2000) have shown that 1,25(OH)2D3 can activate 
subcellular distribution of specific PKC isozymes, and hormone regulated enzyme 
modulation and redistribution were impaired with aging. In addition, Dranitzki-Elhalel et 
al. (1999) suggested that the action of 1,25(OH)2D3 on calcium flux from cultured bone is 
mediated, in part, via activation of PKC. The study of Farhadi et al. (2006) indicated that 
PKC normalized intracellular calcium by modulating calcium efflux. Korchak et al. 
(2001) demonstrated that PKC is the regulator at several points in Ca2+ mobilization in 
neutrophils and HL60 cells. In addition, the Ca2+ dependent PKCs are known to regulate 
the activity of several membrane bound ion channels and carriers in various tissues, 
thereby modulating transmembrane ion transport (Halet et al., 2004), bicarbonate 
transport in rat jejunum (Orsenigo et al., 2002), and Ca2+ pump and Ca2+ channel activity 
in sickle cells (Fathallah et al., 1997).  
In small intestine, various PKC isoforms have been identified at the mRNA or 
protein level, including classical PKCs (cPKCs; Farhadi et al., 2006). Different isotypes 
elicit the differences in tissue expression, subcellular distribution, cofactor requirements 
and substrate specificity (Jiang et al., 1995), and then lead each PKC to have a specific 
function in the signal transduction mechanism.  However, how certain PKC isotypes 
influence  the activation of calcium transport (Balogh et al., 1997; Larsson and Nemere, 
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2003) in the small intestine remains unknown. The purpose of this study was to 
determine which Ca2+ dependent PKCs regulate the calcium efflux system, in order to 
provide a more knowledgeable cellular and molecular mechanism of 1,25(OH)2D3-
stimulated  calcium extrusion. 
Materials and Methods 
Animal and Surgical Methods 
All protocols were approved by the Institutional Animal Care and Use Committee 
at Utah State University (Logan, UT). White leghorn cockerels (Privett Hatchery; 
Portales, NM) were obtained on the day of hatch and raised for 3-7 wks on a vitamin D-
replete diet (Nutrena Feeds; Murray, UT). On the day of the experiments, chicks were 
anesthetized with chloropent (0.3 ml/100 g body weight), the duodenal loop was removed 
to ice-cold 0.9% saline and chilled for 15 min. The pancreas was excised and the 
duodenal loop was everted and rinsed three times with ice-cold saline. 
Cell Isolation  
Intestinal epithelial cells were isolated as previously described (Nemere at al., 
2004; Sterling and Nemere, 2005). The everted duodenal loop was gently stirred for 15 
min at 23oC  in citrate chelation solution containing 96 mM NaCl, 27 mM 
NaCitrate.2H2O, 1.5 mM KCl, 8 mM KH2PO4, 5.6 mM Na2HPO4, pH 5.0. The intestinal 
segment was then transferred to fresh solution and cells released in the previous 
incubation transferred to 50-ml conical centrifuge tubes. The isolation protocol was 
repeated two more times. The cells were collected by low speed centrifugation (500 x g, 
5 min, 4oC). Cell pellets were resuspended in Gey’s Balanced Salt Solution (GBSS, 119 
mM NaCl, 4.96 mM KCl, 0.22 mM KH2PO4, 0.84 mM NaHPO4, 1.03 mM MgCl2.6H2O, 
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0.28 mM MgSO4.7H2O, 0.9 mM CaCl2, pH 7.4). To minimize clumping, the cells were 
gently spread along the walls of the centrifuge tube with a Teflon rod, and room-
temperature GBSS added drop-wise, with stirring, until a suspension was formed.  
Cell suspensions and calcium uptake 
Chicken intestinal cells were isolated by citrate chelation as described above and 
resuspended in room temperature GBSS (23oC) containing 0.1% BSA. Fourteen 
milliliters of cell suspension were pipetted into polypropylene tubes which contained 1 
μCi/ml of 45CaCl2, final concentration (Perkin Elmer Life Sciences, Boston, MA), at T = 
-10 min. Aliquots (3.2 ml) of cell suspensions were pipetted into four fresh tubes and 
samples (100 μl) removed at T = -5 and -1 min to establish basal uptake. At T = 0 min, 
the cells were treated with the vehicle ethanol (final concentration < 0.05%) or 300 pM 
1,25(OH)2D3 to produce the following incubation conditions: (1) controls (2) 300 pM 
1,25(OH)2D3 (3) control plus PKCα blocker (safingol; EMD Chemicals, Gibbstown, NJ) 
(4) 300 pM 1,25(OH)2D3 plus PKCα blocker. Another series of experiments were done 
with the same procedure to produce the following conditions: (1) controls (2) 300 pM 
1,25(OH)2D3 (3) controls plus PKCβ blocker [(3-(1-(3-imidazol-1-ylpropyl)-1H-indol-3-
yl)-4-anilino-1H-pyrrole-2,5-dione; EMD Chemicals, Gibbstown, NJ] (4) 300 pM 
1,25(OH)2D3 plus PKCβ blocker. At T = 1, 3, 5, 7, and 10 min, 100 μl samples were 
pipetted into 900 μl of ice-cold GBSS to stop uptake. Cell samples were placed on ice 
and centrifuged (1,000 x g, 5 min, 4oC) at the end of  the time course. The supernatants 
were decanted and the tubes swabbed with a Kimwipe while still in the inverted position. 
The pellets were resuspended in 500 μl of double-distilled water. The aliquots (100 μl) 
were pipetted into 3 ml of liquid scintillation cocktail for the determination of 
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radioactivity and 20 µl of aliquots taken to determine protein using the Bradford reagent. 
Specific radioactivity (cpm/μg protein) was calculated and then values obtained for the 
treated phase normalized to average basal phase.  
Cell Culture 
For studies with siRNA against PKCα or PKCβ (Dharmacon, Inc., Lafayette, 
CO), cells were resuspended in 40 ml of GBSS and aliquots (0.2 ml) pipetted into 35 mm 
plastic Petri dishes (Falcon, Fisher Scientific; Franklin Lakes, NJ) with 3 ml of RPMI-
1640 medium (Hyclone, Logan, UT), and antibiotics containing 100 units/ml of penicillin 
and 100 µg/ml of streptomycin (Sigma Chemical Co; St. Louis, MO). The cells were 
incubated overnight at 37oC, 5% CO2/95% air without serum to promote cell adherence. 
The following day, medium was aspirated and the cells were transfected with SiImporter 
(Millipore, Bedford, MA) as described by the manufacturer’s product protocol (Upstate, 
Lake Placid, NY, 2005) with 100 nM siRNA,  final concentration (Dharmacon, inc., 
Lafayette, CO). Briefly, for each plate 930 µl of RPMI-1640 medium was combined with 
65 µl of a solution containing 5 µl of SiImporter, 25 µl of siRNA diluent, 35 µl of RPMI-
1640 and  5 µl of siRNA (transfected cells) or scrambled RNA (Santa Cruz 
Biotechnology, Santa Cruz, CA) or without siRNA (mock transfected cells), mixed 
gently and incubated at room temperature for 5 min. The transfection mixture was then 
added to the cultured cells and incubated for 4 h After the incubation period, 3 ml of 
RPMI-1640 with 10% FBS and antibiotics were added to each Petri dishes (Falcon 
Scientific Products; Franklin Lakes, NJ). Incubation was continued for 24 h at 37oC, 5% 
CO2/95% air and the cultures were assayed for calcium uptake as described below.   
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Calcium Uptake  
After 48 h of incubation, the medium was aspirated and replaced with 1 ml of 
GBSS containing 0.1% BSA (23oC). At T = 0, an equal volume of buffer was added 
containing radioactivity (1 µCi of 45CaCl2 [Perkin Elmer Life Sciences, Boston, MA] per 
ml, final concentration) and either vehicle (0.012% ethanol, final concentration) or 300 
pM 1,25(OH)2D3 (final concentration), and the incubation continued for 7 min—a time 
found earlier to be optimal for observing hormone-mediated differences in uptake (Peery 
and Nemere, 2007). Media were then aspirated and the cells were rinsed with 4 ml of ice-
cold GBSS three times, followed by the addition of 0.5 ml of lysis buffer (0.1% (v/v) 
triton X-100 in TED containing 10 mM Tris, 1.25 mM EDTA, 2mM dithiothreitol, pH 
7.4). Cells were scraped, solubilized,  and collected for determination of radioactivity by 
liquid scintillation spectrophotometry and protein.  
Confocal Microscopy 
Intestinal cells were isolated by citrate chelation and resuspended in 40 ml of GBSS. 
A coverslip was placed in the bottom of each Petri dish and 3 ml of RPMI 1640 and 0.5 
ml of cell suspension added. The cells were cultured overnight. The following morning, 
media were replaced with 1 ml of GBSS containing 0.1% BSA. At T = 0 min, either 
vehicle (0.001% ethanol, final concentration), 130-, 300-, or 650 pM 1,25(OH)2D3 were 
added. At T = 30 sec, media were replaced with 1 ml of 3% paraformaldehyde, 3% 
sucrose in PBS and the cells were fixed for 20 min. After washing three times with PBS, 
cells were permeabilized for 5 min with 0.1% Triton X-100 in PBS, washed three times 
with PBS, and incubated with primary antibody (rabbit anti-PKCα or mouse anti-PKCβ,  
1/500 dilution with PBS-0.1% BSA; both from Zymed, San Francisco, CA) for 30 min, 
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followed by three washes with PBS. Cells were then incubated with fluorescein-
conjugated secondary antibody (Jackson Immunoresearch, West Grove, PA) for 30 min, 
washed three times and mounted on 10% 1 M Tris in 80% glycerol on a microscope 
slide. Coverslips were blotted, and sealed with nail polish. Prepared samples were 
analyzed using a BioRad MRC 1024 laser-scanning confocal microscope system 
mounted in the Keller position and attached to a Nikon TE-200 microscope. Images were 
captured with BioRad LASERSHARP acquisition software, using a 40x objective lens 
(Sterling and Nemere, 2007).  The images were analyzed for pixel intensity using Adobe 
Photoshop 6.0 (Adobe Systems, Inc., San Jose, CA). Briefly, the intensities of intestinal 
cells were divided into four parts as follows; BBM, Apical part (two third of the intestinal 
cells), BBM and apical part, and BLM (one third of the intestinal cells). The diagram of 
intestinal epithelial cells were shown in Fig 3.1. 
     
Fig. 3.1 Diagram of different regions of intestinal epithelial cells 
Protein Determination 
The protein concentration was determined using Bradford reagent (BioRad) and 
bovine γ-globulin as the protein standard. 
 
Brush border membrane (BBM) 
Apical region 
Basolateral membrane (BLM) 
Basal region 
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Statistical Analysis 
All values were expressed as mean + SEM. Statistical comparisons between two 
treatment groups were compared by one way ANOVA (SigmaStat 3.1 and SigmaPlot 
9.0). Significant differences were considered to occur at P < 0.05. 
Results 
Effect of PKCα blocker (safingol) on                  
1,25(OH)2D3-mediated calcium extrusion 
 
 To determine whether PKCα mediates calcium extrusion, freshly isolated 
intestinal cells were treated with vehicle or 300 pM 1,25(OH)2D3. in the absence or 
presence of inhibitor, and aliquots removed at the indicated times. The results from 
experiments using the chemical PKCα blocker demonstrated no difference in calcium 
extrusion (lack of altered calcium uptake) in  vehicle controls, 1,25(OH)2D3 treated, 
vehicle control plus PKCα blocker or 1,25(OH)2D3 plus PKCα blocker groups (Fig 3.2).  
Therefore, it is likely that PKCα is not the PKC isotype involved in steroid hormone-
stimulated calcium efflux from intestinal epithelial cells. 
Effect of PKCβ blocker [(3-(1-(3-imidazol-1-ylpropyl)-          
1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione] on                                                      
1,25(OH)2D3-mediated calcium extrusion  
 
The equivalent experiments were undertaken to study the involvement of 
PKCβ on calcium efflux. The effect of the chemical PKCβ inhibitor was to cause a 
significant decrease in calcium extrusion (increase in calcium uptake) in cells treated with 
300 pM 1,25(OH)2D3 plus PKCβ blocker at 3, 5, 7 and 10 min (1.311 + 0.086bb, 1.396 + 
0.168bbb, 1.454 + 0.160bb and 1.400 + 0.067bb, respectively, bb,bbbP < 0.01, 0.001) when 
compared with 1,25(OH)2D3  at the corresponding time points (1.025 + 0.062, 0.993 + 
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Fig. 3.2 Effect of the chemical PKCα blocker (safingol) on calcium uptake in intestinal 
cell suspensions. Enterocytes isolated by citrate chelation were resuspended in Gey’s 
Balanced Salt Solution (GBSS; 23oC) containing 0.1% BSA and combined with 2 μCi/ml 
of H332PO4, final concentration, at the start of the time course studies. Aliquots of cells 
were pipetted into four fresh tubes and samples (100 μl) were removed at T = -5 and -1 
min to establish basal uptake. At T = 0 min, the cells were treated with the vehicle 
ethanol (final concentration < 0.05%) or 300 pM 1,25(OH)2D3 to produce the following 
incubation conditions: (1) controls (open circles)      (2) 300 pM 1,25(OH)2D3  (closed 
circles) (3) controls in the presence of the PKCα blocker (open triangles) (4) 300 pM 
1,25(OH)2D3 in the presence of the PKCα blocker (closed triangles). Data are presented 
as mean treated/average basal ratios + SEM. 
 
0.087, 1.001 + 0.094 and 0.963 + 0.096, respectively; Fig 3.3). The percentage decrease 
in calcium efflux was approximately 29 (3 min), 40 (5 min), 45 (7 min) and 44% (10 
min) when compared to cells treated with PKCβ blocker plus 1,25(OH)2D3 and cells 
treated with hormone alone. 
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Fig. 3.3 Effect of the chemical PKC β blocker ([3-(1-(3-Imidazol-1-ylpropyl)-1H-indol-
3-yl)-4-anilino-1H-pyrrole-2,5-dione]) on calcium uptake in intestinal cells suspension. 
Another series of experiments were done with the same procedure as described in Fig. 3.2 
to produce the following conditions:   (1) controls (open circle)  (2) 300 pM 1,25(OH)2D3 
(closed circles)  (3) controls in the presence of the PKCβ blocker  (open triangles) (4) 300 
pM 1,25(OH)2D3 in the presence of the PKCβ blocker (closed triangles). At T = 1, 3, 5, 
7, and 10 min, 100 μl samples were pipetted into 900 μl of ice-cold GBSS. Cell samples 
were centrifuged (1,000 x g, 5 min, 4oC), supernatants decanted and pellets analyzed for 
radioactivity and protein. Specific radioactivity (cpm/μg protein) was calculated and then 
values obtained for the treated phase were normalized to average basal phase. Data are 
presented as mean treated/average basal ratios + SEM. (aa,bb,cc P < 0.01 and aaa,bbb,ddd P < 
0.001, relative to controls, 1,25(OH)2D3 and controls plus PKCβ blockers, respectively). 
 
Effect of siRNA against PKCα on calcium                    
extrusion in cultured intestinal cells 
   
 The results of the previous studies suggested that PKCβ is the isotype most likely 
mediating 1,25(OH)2D3-stimulated calcium extrusion in intestinal epithelial cells. We 
first further investigated the effect of knockdown of PKCα gene expression on calcium 
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efflux. In this study, we cultured intestinal cells as previously described (Nemere et al., 
2004; Sterling and Nemere, 2005), and transfected primary intestinal cell cultures with 
siRNA against PKCα. Cells were treated with vehicle control or 300 pM steroid 
hormone. The result was that no difference was observed between nontransfected and 
transfected cells (Fig 3.4).   
Effect of siRNA against PKCβ  on calcium                                   
extrusion in cultured intestinal cells. 
  
 Under the same conditions as the previous experiments, siRNA against PKCβ 
resulted in a significant increase in calcium uptake in hormone treated (169.39 + 3.55aaa 
cpm/μg protein, P < 0.001), relative to nontransfected controls and hormone treated 
(82.66 + 2.06, 144.05 + 4.03 cpm/μg protein, respectively) and mock transfected cells 
(79.59 + 2.30 cpm/μg protein). No difference was found in nontransfected cells and cells 
transfected with scrambled siRNA (Fig 3.5). Western blots with anti-PKCα and anti-
PKCβ verified the protein expression was decreased approximately by 40% (data not 
shown).  
Effect of 1,25(OH)2D3 on anti-PKCα immunofluorescence           
distribution as judged by confocal microscopy  
 We used confocal microscopy to determine the involvement of PKCα in steroid 
hormone-mediated signal transduction. Intestinal cells were cultured on cover slips, 
treated with vehicle or 130-, 300-, or 650 pM 1,25(OH)2D3 for 30 sec in order to 
assessthe redistribution of PKCα. Cultured cells were incubated with anti-PKCα and the 
brushborder membranes were stained with rhodamine-conjugated phalloidin. Non 
specific staining controls were negative (data not shown). Fig 3.6A demonstrates the 
distribution of fluorescein conjugated secondary antibody to anti- PKCα which was 
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Fig. 3.4 Effect of siRNA to PKCα on calcium uptake in cultured intestinal cells. Isolated 
cells were resuspended in 40 ml of GBSS and 200 µl pipetted into 35 mm plastic Petri 
dishes containing 3 ml of RPMI-1640 medium and antibiotics (100 units/ml penicillin, 
100 mg/ml streptomycin, Sigma). The cells were incubated for 24 h (in the absence of 
serum) at 37 °C with 5% CO2/95% air and then transfected. The transfection protocol is 
described in materials and methods. After 24 h cultured cells were incubated with or 
without 300 pM 1,25(OH)2D3 in 1 ml of GBSS/0.1% (wt/vol) BSA containing 4 µCi of 
H332PO4 for 7 min. The cells were rinsed 3 times with 4 ml ice-cold GBSS, followed by 
the addition of 0.5 ml of 0.1% (vol/vol) Triton X-100 in 10 mM TED to each plate. Cells 
were scraped and radioactivity determined by liquid scintillation counting. Data are 
represented as mean + S.E.M. (***P < 0.001, relative to corresponding controls).  
 
found to be greater in the apical part of intestinal cells treated with 300- and 650 pM (P < 
0.01, 0.001, respectively) than in controls or in the 130 pM treatment group. The graph 
shown in Fig 3.6B depicts the results of confocal microscopy as pixel intensity with the 
data were corrected for non specific controls. The percentage increase in pixel intensity  
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Fig. 3.5 Effect of siRNA to PKCβ on calcium uptake in cultured intestinal cells. Cells 
were cultured and treated as described in Fig. 3.3. Data are represented as mean + S.E.M. 
(aa, ***P < 0.01, 0.001, relative to corresponding hormone-treated and vehicle controls, 
respectively).  
 
was 21 % and 25% in the apical region of the cells and 15% and 26% in brush border 
plus apical area in 300- and 650 pM steroid-treated cells, respectively, when compared 
with the vehicle controls. There were no differences in pixel intensity in brush borders or 
basal lateral membranes alone. This result showed that there was rapid redistribution of 
PKCα when the cells were treated with hormone. 
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Fig. 3.6A Immunocytochemical localization of PKCα in isolated intestinal cells. 
Intestinal cells were isolated by citrate chelation as described in materials and methods. 
The cells were cultured overnight. The following morning, media were aspirated and 
replaced with 1 ml of GBSS containing 0.1% BSA. At T = 0 min, either vehicle (0.001% 
ethanol, final concentration), 130-, 300-, or 650 pM 1,25(OH)2D3 were added. At T = 30 
sec, media were aspirated and replaced with 1 ml of 3% paraformaldehyde, 3% sucrose in 
PBS, and the cells were fixed. After washing three times with PBS, cells were 
permeabilized for 5 min with 0.1% Triton X-100 in PBS, washed three times with PBS, 
and incubated with primary antibody (rabbit anti PKCα, 1/500 dilution) with PBS-0.1% 
BSA for 30 min, followed by three washes with PBS. Cells were then incubated with 
fluorescein-conjugated secondary antibody for 30 min, washed three times and mounted 
on 10% 1 M TRIS in 80% glycerol on microscope slide. Coverslip were blotted, and 
sealed with nail polish.  
 
Effect of 1,25(OH)2D3 on anti-PKCβ immunofluorescence           
distribution as judged by confocal microscopy  
 Fig 3.7A shows the distribution of fluorescein-conjugated secondary antibody to 
anti- PKCβ.  In contrast to the distribution of anti-PKCα, the anti-PKCβ fluorescein was 
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Fig. 3.6B Quantitative analysis of the distribution of fluorescence intensity. The graph 
presents the mean pixel intensity of fluorescein-conjugated secondary antibody against 
anti-PKCα in different cellular regions. Data represent mean + SEM (**, *** P < 0.01, 
0.001 when compared with the corresponding controls). 
 
found to be greater in the basal lateral region of intestinal cells treated with 300- or 650 
pM (P < 0.01, 0.05, respectively) when compared with controls and the 130 pM treatment 
group.            
 Figure 3.7B presents these results in graphic form in which pixel intensity is 
corrected for non specific staining controls. The percentage increase in pixel intensity 
was 18% and 13% in the basal lateral region of cells treated with 300- and 650 pM,  
60 
 
 
 
Fig. 3.7A Immunocytochemical localization of PKCβ in isolated intestinal cells. Cells 
were prepared and treated as described in Fig. 3.5 (A), except the cells were incubated 
with mouse anti-PKCβ, 1/500 dilution as the primary antibody. 
 
respectively, when compared with vehicle controls. There were no differences in pixel 
intensity in other cellular regions. These results demonstrate that PKCβ was redistributed 
after incubating  cells with 1,25(OH)2D3. 
Discussion 
Using Forskolin, a PKA activator, we have reported elsewhere that the PKA 
signaling pathway is the mediator of calcium uptake in intestinal cells (Phadnis and  
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Fig 3.7B Quantitative analysis of the distribution of fluorescence intensity. The graph 
presents the mean pixel intensity of fluorescein-conjugated secondary antibody to anti-
PKCβ at different cellular regions. Data are presented as mean + SEM (*,** P < 0.05, 
0.01 when compared with corresponding controls). 
 
Nemere, 2003; Sterling and Nemere, 2007; Khanal et al., 2008), whereas the study by 
Nemere and Campbell (2000) has identified that PKC signaling is involved in calcium 
extrusion.  A recent study (Khanal et al., 2008) has reported that phorbol ester, a PKC 
activator, stimulated Ca2+ efflux, and forskolin stimulated uptake. Furthermore, our 
previous study (see Chapter 2) showed the dose response curve of 1,25(OH)2D3-
stimulated PKCβ activity exhibited activation at both 300- and 650 pM hormone, which 
corresponds with the curve for activated calcium transport (Nemere et al., 1984).    
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In the current study, we used chemical blockers for PKCα and PKCβ and found 
that use of the PKCβ blocker resulted in stimulated calcium uptake in intestinal cells 
treated with 1,25(OH)2D3. This result indicates that the increase in calcium uptake, 
resulting from an inhibition of calcium efflux from the cells was due to the 1,25(OH)2D3 
mediated PKCβ signal transduction pathway. While equivalent experiments were 
performed to identify the involvement of PKCα, the results showed there was no 
difference in calcium uptake in cells treated with the PKCα blocker plus steroid hormone 
when compared to the vehicle control and hormone treated cells alone. From this result, it 
is likely to conclude that PKCα in not involved in 1,25(OH)2D3-mediated calcium 
extrusion. 
Correspondingly, the experiment with siRNA against PKCβ in primary intestinal 
cell cultures showed an increase in calcium uptake (in turn, decreased calcium extrusion) 
of 25% when compared with cells treated with 1,25(OH)2D3. This result is lower than 
with the chemical inhibitor and can be explained by the loss of PKC activity after 72 h of 
incubation in cell culture (Khanal et al., 2008). In comparison, siRNA against PKCα 
demonstrated no difference in calcium uptake in all treatment groups of both transfected 
and nontransfected cells. From the chemical blockers and transfection studies, our 
findings clearly indicate that PKCβ is the PKC isotype that mediates the 1,25D3-MARRS 
receptor-stimulated calcium extrusion in intestinal epithelial cells whereas PKCα and 
PKCβ are involved in steroid-enhanced phosphate uptake (see Chapter 2).   
 Our study was similar to the study of Farhadi et al. (2006) in Caco-2 cells, where 
they reported that PKCβ protects the intestinal cell from oxidant-induced injury through 
PKC normalized intracellular calcium by modulating calcium efflux. By contrast, 
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Fathallah et al. (1997) have studied the effect of PKC in deoxygenated sickle cells and 
suggested that PKCα stimulated Ca2+ efflux by mediating the phosphorylation of a Ca2+ 
pump or an associated protein. In addition, Korchak et al. (2001) has report that PKCβ 
regulates ligand-initiated Ca2+ uptake in differentiated HL60 cells. 
By using confocal microscopy, we have identified the translocation of PKCβ to 
the basal lateral region of intestinal cells whereas PKCα translocated to the apical part in 
cells treated with different concentration of steroid hormone within 30 sec. The 
difference in PKC translocation might be because these two PKC isotypes function 
differently in 1,25(OH)2D3-mediated ion transport since individual isotypes have distinct 
and specialized functions in cell signaling (Jiang et al., 1995). However, a similar result 
has been reported. Sitrin et al. (1999), demonstrated that 1,25(OH)2D3 rapidly stimulates 
the translocation of PKCβ, to the basolateral membrane, not the brush border membrane. 
However, they found that PKCα, did not translocate to either antipodal plasma 
membrane. Balogh et al. (2000) also demonstrated that 1,25(OH)2D3 affects the 
subcellular distribution of PKCα, β and δ and these effects are impaired with aging. 
These results might be different because of the tissue specificity and species; we have 
studied chick intestinal epithelial cells whereas they studied rat colonic cells.  
 However, the exact mechanism involved in 1,25(OH)2D3 mediated calcium 
extrusion is still unknown. It might be that PKC stimulated vesicular transport of calcium 
(Sterling and Nemere, 2005) in either a receptor mediated or non receptor mediated 
pathway (Le et al., 2002; Le Roy and Wrana, 2005; Alvi et al., 2007).  Alternatively, 
1,25(OH)2D3 has been reported to upregulate plasma membrane Ca2+-ATPase expression 
(Kip and Strehler, 2004) and studies of PKC in many cell types have shown increased 
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activity of  Ca2+-ATPase and that it is activated by PKC (Kanashiro and Khalil, 1998). In 
conclusion, we suggest that PKCβ mediates signal transduction for the 1,25D3-MARRS 
receptor (ERp57/PDIA3) in steroid hormone-stimulated calcium extrusion in chick 
intestinal epithelial cells, either by the regulation of exocytosis through the basal lateral 
membrane and/or by activation of Ca2+-ATPase on the basal lateral membrane of chick 
enterocytes. 
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CHAPTER 4 
SUMMARY AND CONCLUSION 
Summary 
1,25-dihydroxyvitamin D3 [1,25(OH)2D3] is the steroid hormone that regulates 
phosphate and calcium homeostasis. The effects of this secosteroid hormone on its target 
organs are mediated in part by classical mechanisms via a nuclear vitamin D receptor 
(nVDR). This slow action modulates gene transcription to generate genomic responses in 
cells (Christakos et al., 2003; Norman et al., 2004).  In addition to this slow response 
mechanism, 1,25(OH)2D3 also a rapid action through the 1,25D3-MARRS receptor to 
generate pregenomic actions such as modulation of ion transport, membrane fluidity and 
generation of signal transduction inside cells (Nemere et al., 1994; de Boland and 
Norman, 1998; Nemere et al., 1998; Fleet, 2004).     
 From the previous studies in chick intestinal epithelial cells and 
immunohistochemistry, we found that 1,25(OH)2D3-mediated rapid uptake of phosphate 
(Zhao and Nemere, 2002; Peery and Nemere, 2007) and extrusion of calcium (Nemere 
and Campbell, 2000) is mediated by a PKC signal transduction mechanism.  
 The mechanism of signal transduction by PKC begins with the binding of receptor 
to ligands such as hormones and growth factors to activate phospholipase C. The 
phospholipase C hydrolyses phosphatidylinositol 4,5 bisphosphate (PIP2) and produces 
two secondary messengers: inositol 1,4,5-triphosphate (IP3) and diacylglycerol (DAG). 
The latter molecule can then activate PKC (Kanashiro and Khalil, 1998). There are 
several isotypes of PKC that are different in their structure, function and tissue 
expression. In this study, I focused on the classical PKC which includes PKCα, β and γ. 
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 The first series of experiments were performed to determine which isotype(s) of 
protein kinase C (PKC) is/are activated by the 1,25D3-MARRS receptor (ERp57/PDIA3) 
which has been reported to be a plasma membrane receptor for 1,25(OH)2D3  (Nemere et 
al., 2004) in hormone stimulated phosphate uptake. The present work demonstrated that 
1,25(OH)2D3 rapidly stimulated phosphate uptake within 1 min with the highest 
immunoreactivity in the P2 fractions of cells treated with 300 pM  1,25(OH)2D3 in 
western blots with anti-PKCα and 300 pM- and 650 pM-steroid hormone for anti-PKCβ. 
Therefore, we used these two PKC isotypes for the next experiments. The studies with 
siRNA to PKCα and PKCβ and chemical inhibitors of PKCα (safingol) and PKCβ ([3-
(1-(3-Imidazol-1-ylpropyl)-1H-indol-3-yl)-4-anilino-1H-pyrrole-2,5-dione]) 
demonstrated the involvement of these two isotypes in 1,25(OH)2D3-mediated phosphate 
uptake in chick intestinal epithelial cells. Therefore, it is likely to be that PKCα and 
PKCβ are the PKC isotypes that regulate phosphate homeostasis in the small intestine. 
Our finding is similar to the study in rat duodenum (Balogh et al., 2000) and colon (Wali 
et al., 1998, Sitrin et al., 1999). These workers found that 1,25(OH)2D3-enhanced the 
redistribution of PKC α, β, and δ to the basal lateral membrane.  Therefore, the PKC 
signal transduction pathway is likely to mediate the rapid pregenomic actions of 
1,25(OH)2D3 in intestine. In addition, 1,25(OH)2D3 was also found to activate the MAP 
kinase pathway in chick enterocytes (de Boland and Norman, 1998). The mechanism of 
steroid stimulated phosphate uptake may possibly be through the exocytosis of NaPi 
cotransporters which are found at the brush border membrane of intestinal cells (Biber et 
al., 2009). These transporters are involved in the uptake of phosphate across the 
membrane. In parathyroid hormone (PTH) stimulation of kidney cells, PKC is suggested 
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to phosphorylate a stabilizing protein of the NaPi contransporter that weakens the affinity 
to activate the delivery of the transporter to the endocytic machinery (Gisler et al., 2001; 
Weinman et al., 2007).  Furthermore, signal transduction by PKC might involve 
membrane trafficking and the vesicular transport of endocytic vesicles across epithelial 
cells (Sterling and Nemere, 2005). 
Further experiments were done to examine the involvement of PKC isotypes in 
steroid-activated calcium extrusion.  The current work demonstrated that a chemical 
inhibitor of PKCβ, but not PKCα, in intestinal cell suspension studies can significantly 
inhibit 1,25D(OH)2D3-stimulated calcium efflux from intestinal epithelial cells by 50%. 
Similar results were also found in further experiments with transfection of siRNA to 
PKCα or PKCβ in intestinal primary cell culture. The results also indicated that there was 
no change in calcium extrusion in cells transfected with siRNA to PKCα, whereas the 
siRNA to PKCβ significantly decreased calcium extrusion (resulting in increased calcium 
uptake) in 1,25(OH)2D3-treated cells when compared with the vehicle controls. 
Confocal microscopy experiments were undertaken to assess the redistribution of 
PKCα and PKCβ in cells exposed to steroid hormone as early as 30 seconds.  PKCα was 
found to significantly increase in the apical membrane after a 1 minute exposure of cells 
to 300- or 650 pM 1,25(OH)2D3.  By comparison, anti-PKCβ immunofluorescence was 
found to increase significantly in the basal region of cells, relative to controls, following 
exposure of cells to 300 pM secosteroid.  The combined results demonstrate that PKCβ is 
the PKC isotype that is involved in the control of calcium homeostasis by pumping out 
the calcium from the cells to prevent cytotoxicity.  Vitamin D3 has been reported to 
upregulate Ca2+-ATPase expression and increase transcellular calcium flux from the 
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apical to the basolateral side in kidney cells (Kip and Strehler, 2004). The mechanism of 
PKC in the signal transduction pathway to regulate the extrusion of calcium might be 
from the increase in Ca2+-ATPase phosphorylation and Ca2+ pump activity (Wright et al., 
1993). Fathallah et al (1997) reported the activation of PKCα on Ca2+ pump activity in 
sickle cells, the difference in PKC isotypes are from the difference in species and tissue 
expression of PKC. Another possible mechanism might be the stimulation of exocytosis 
of lysosomal vesicles containing Ca2+ in the vesicular transport model (Nemere et al., 
1994;Larsson and Nemere, 2002; Khanal et al., 2008; Khanal and Nemere, 2008). The 
mechanism and the model of PKC signal transduction through 1,25D3-MARRS receptor 
are shown in Fig. 4.1, and Fig. 4.2, respectively. 
Conclusion 
From these recent results, we then can conclude that    
 1. 1,25(OH)2D3-stimulated rapid phosphate uptake and calcium extrusion occur 
within seconds, via a pregenomic pathway       
 2. PKCα and PKCβ play a role in the signal transduction mechanism of 
1,25(OH)2D3-mediated phosphate uptake, possibly via the phosphorylation of Na/Pi 
cotransporters and/or the regulation of endocytic vesicular transport of phosphate  
 3. PKCβ is involved in the mechanism of  1,25(OH)2D3-mediated calcium efflux 
in chick intestinal epithelial cells by the regulation of exocytosis through the basal lateral 
membrane and/or by activation of Ca2+-ATPase or other calcium transporters on the basal 
lateral membrane of chick enterocytes. 
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Future Study 
1. Evaluation of the role of PKC in mediating phosphate and calcium transport in 
aging animals 
2. Determination of the possible mechanism involved in PKCα and PKCβ signal 
transduction through 1,25D3-MARRS receptor-induced phosphate uptake and calcium 
extrusion 
Benefit 
This study provides the basic knowledge of cellular and molecular mechanism of 
1,25(OH)2D3 regulated phosphate and calcium homeostasis. The results from this 
research  may suggest new ways to develop drugs or therapies to improve phosphate and 
calcium uptake. Some of therapies may include the means of direct stimulation of 
specific PKC isotype in the intestine. This development will promote bone health and 
overcome phosphate and calcium malabsorption in response to bone diseases, aging or 
patients with chronic renal failure or hyperparathyroidism. Also, this will provide a better 
understanding of how cells can maintain their calcium homeostasis in between the input 
(absorption) and the output (extrusion) to protect the cells from toxicity.   
 Furthermore, this study also has implications in agriculture. The production of 
manure high in phosphate in poultry farms is a serious problem since it has had an effect 
on ecology.  The combined research can be used to benefit crop production and would 
help minimize the phosphate levels in manure. 
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Fig. 4.1 (A) 1,25(OH)2D3 binds to 1,25D3-MARRS receptor (B) the extracellular signal 
induces membrane enzyme which is called phospholipase C (PLC), resulting in the 
production of diacylglycerol (DAG) and inositol triphosphate (IP3). Intracellular calcium 
(Ca2+) releases from the sarcoplasmic reticulum (SER) (C) DAG and Ca2+ causes 
activation and translocation of protein kinase C (PKC) from the cytosolic part to 
membrane. (D) PKC directly phosphorylates cellular substrates and leads to the alteration 
in cellular responses (E) In this case, PKCα and/or β phosphorylates Ca2+-ATPase and 
NaPi cotransporter, resulting in the transport of calcium or phosphate from their absortive 
site to the circulation. 
A 
B 
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Fig. 4.2 Schematic model of PKCα and PKCβ signal transduction through the 1,25D3-
MARRS receptor in 1,25(OH)2D3-stimulated phosphate uptake and calcium extrusion. 
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Appendix 
Abbreviations 
μCi      Microcurie, a unit of radiation 
μg      Microgram 
μl      Microliter 
1,25(OH)2D3     1,25-dihydroxyvitamin D3 
1,25D3-MARRS 1,25-dihydroxyvitamin D3 membrane 
associated, rapid response steroid-binding 
receptors 
32P Radioisotope for phosphorous 
45Ca Radioisotope for calcium 
Ab593 Antibody 593, used to block 1,25D3-
MARRS receptor 
ANOVA Analysis of variant 
Anti-pan PKC Antibody detects endogenous levels of 
almost all protein kinase C isoforms 
aPKC Atypical protein kinase C 
BBM Brush border membrane (luminal side) 
BLM Basolateral membrane (serosal side) 
BSA Bovine serum albumin 
Ca2+-ATPase Plasma membrane calcium transporter 
protein 
cPKC Conventional protein kinase C 
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P1 fraction Pellets contain nuclei, BBM and large cell 
debris 
P2 fraction Pellets contain BLM, Golgi, mitochondria, 
lysosomes and peroxisomes 
CPM Counts per minute, a measurement of 
radioactivity 
DAG Diacylglycerol 
ECF substrate Enhanced luminescence substrate 
ERp57 Membrane protein of the endoplasmic 
reticulum 
IP3 Inositol 1,4,5-triphosphate 
MAP kinase Mitogen-activated protein kinase, a 
serine/threonine protein kinase 
mM Millimolar 
Min Minute 
nPKC Novel protein kinase C 
Npt2b Sodium Phosphate cotransporter isoform 
type 2b 
NTF Nontransfected cells 
PBS Phosphate buffer saline 
PDIA3 Protein disulfide isomerase 
PIP2 Phosphotidylinositol 4,5-bisphosphate 
PKA Protein kinase A 
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PKC  Protein kinase C 
PLC Phospholipase C 
pM Picomolar 
PTH Parathyroid hormone 
P value Probability to test the hypothesis 
SDS-PAGE Sodium dodecyl sulfate polyacrylamide gel 
electrophoresis 
Sec Second 
SEM Standard error of mean 
siRNA Small interfering RNA 
T Time 
TF Transfected cells 
TRPV6 Transient receptor potential of the vanilloid 
type, type of membrane calcium channel 
VDR Vitamin D receptor 
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